Cyra 40 Tablet
Marketer
Systopic Laboratories Pvt Ltd
Salt Composition
Rabeprazole (40mg)
Overview Cyra 40 Tablet
Gastro-acid reducer, Cyra 40mg tablets, diminishes stomach acid production. It treats acid-related gastrointestinal disorders including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and fostering healing. Administer one tablet an hour before meals, ideally in the morning. Dosage is condition and response dependent; consistent daily timing, as prescribed, is crucial, even if symptoms subside rapidly. Dietary adjustments, such as smaller, more frequent meals, and avoidance of caffeine, spicy foods, and fatty meals, may enhance symptom management. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Persistent or bothersome side effects warrant medical attention. Prolonged use (over a year), particularly at higher doses, elevates bone fracture risk. Discuss bone loss prevention strategies, like calcium and vitamin D supplementation, with your physician. Hypomagnesemia (low blood magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor your magnesium levels. Cyra 40mg is contraindicated in individuals with severe hepatic impairment, those on HIV medication, those with a history of similar medication allergy, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Cyra 40 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Cyra 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cyra 40 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Cyra 40 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Cyra 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Cyra 40 Tablet on an empty stomach.
How Cyra 40 Tablet works:
Stomach acid production is decreased by Cyra 40 Tablet, a proton pump inhibitor (PPI), providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cyra 40 Tablet necessitates careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Cyra 40 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding mothers should likely avoid Cyra 40 Tablet. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Cyra 40 Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Cyra 40 Tablet presents no safety concerns for patients with kidney impairment; dosage modification is unnecessary.
LiverSAFE IF PRESCRIBED
Use of Cyra 40 Tablet is considered safe for individuals with hepatic impairment. No alteration of the Cyra 40 Tablet dosage is necessary.
What if you forget to take Cyra 40 Tablet :
Should you forget to take a Cyra 40 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cyra 40 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Gastric acid suppressants |





